Microglia/macrophage-derived human CCL18 promotes glioma progression via CCR8-ACP5 axis analyzed in humanized slice

Yimin Huang1, Edyta Motta2, Cynthia Nanvuma3

  • 1Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert Roessle Strasse 10, 13125 Berlin, Germany; Charité-Universitätsmedizin, 10117 Berlin, Germany; Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, 430030 Wuhan, China.

Cell Reports
|April 13, 2022
PubMed

Insights

Microglia/macrophage-derived CCL18 cytokine promotes glioblastoma growth and invasion. Researchers identified chemokine receptor 8 (CCR8) and acid phosphatase 5 (ACP5) as key signaling components in this process.

Area of Science:

  • Neuroscience
  • Immunology
  • Oncology

Background:

  • Glioma-associated microglia/macrophages (GAMs) significantly influence glioblastoma multiforme (GBM) progression.
  • CCL18, a cytokine found in human GAMs but not rodent GAMs, is implicated in modulating glioma growth.

Purpose of the Study:

  • To investigate the role of CCL18 in promoting glioma growth and invasion.
  • To identify the specific receptor and downstream signaling pathways involved in CCL18-mediated glioma progression.

Main Methods:

  • Development of a humanized glioma model using induced pluripotent stem cell-derived human microglia and human glioma cells in mouse brain slices.
  • Utilizing in vitro, ex vivo, and in vivo GBM models to study CCL18 signaling.
  • Identifying the functional receptor for CCL18 on glioma cells and downstream signaling molecules.

Main Results:

  • CCL18 significantly enhances glioma cell growth and invasion in the humanized model.
  • Chemokine (C-C motif) receptor 8 (CCR8) was identified as the functional receptor for CCL18 on glioma cells.
  • Acid phosphatase 5 (ACP5) was revealed as a crucial mediator in the downstream signaling pathway for CCL18-induced glioma growth.

Conclusions:

  • Microglia/macrophage-derived CCL18 is a key factor promoting glioma growth.
  • The CCL18-CCR8-ACP5 axis represents a potential therapeutic target for GBM treatment.

Related Concept Videos